A First-in-human Dose-escalation and Expansion Study With the Antibody-drug Conjugate BYON3521
Condition(s):Solid TumorLast Updated:May 26, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Solid TumorLast Updated:May 26, 2023Recruiting
Condition(s):Advanced Solid TumorLast Updated:October 28, 2022Completed
Condition(s):Unspecified Adult Solid Tumor, Protocol SpecificLast Updated:September 22, 2023Suspended
Condition(s):NSCLC; NSCLC Stage IV; NSCLC Stage IIIB; Non-Small Cell Lung Cancer; Advanced Non-Small Cell Squamous Lung Cancer; Advanced Non-Small Cell Lung Cancer; Advanced Non-Small Cell Non-Squamous Lung CancerLast Updated:March 28, 2024Recruiting
Condition(s):Solid TumorLast Updated:February 20, 2024Recruiting
Condition(s):Recurrent Squamous Cell Lung Carcinoma; Stage IV Squamous Cell Lung Carcinoma AJCC V7Last Updated:October 18, 2021Completed
Condition(s):Advanced Solid Tumors CancerLast Updated:July 17, 2023Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.